Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment
Authors
Keywords
Tumor microenvironment, Vaccine, Gamma–delta T cells, NKT cells, Cellular immunity, Gastrin
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-24
DOI
10.1007/s00262-019-02398-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- γδ TCR ligands: the quest to solve a 500-million-year-old mystery
- (2019) Benjamin E. Willcox et al. NATURE IMMUNOLOGY
- CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy
- (2018) Qi-Feng He et al. Briefings in Functional Genomics
- Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
- (2018) Kazuma Kiyotani et al. CANCER SCIENCE
- Regulation of Memory CD8+ T Cell Differentiation by MicroRNAs
- (2018) Zhen Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Gamma-delta (γδ) T cells: friend or foe in cancer development?
- (2018) Yijing Zhao et al. Journal of Translational Medicine
- Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
- (2018) Marc Hilmi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma
- (2017) Philipp Lohneis et al. EUROPEAN JOURNAL OF CANCER
- Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice
- (2017) Naveena B. Janakiram et al. IMMUNOLOGY
- Induction of resident memory T cells enhances the efficacy of cancer vaccine
- (2017) Mevyn Nizard et al. Nature Communications
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
- (2016) Timothy M Nywening et al. LANCET ONCOLOGY
- Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed
- (2016) R. Abu Eid et al. Cancer Immunology Research
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
- (2015) A. Patnaik et al. CLINICAL CANCER RESEARCH
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cholecystokinin octapeptide regulates the differentiation and effector cytokine production of CD4+ T cells in vitro
- (2014) Jing-Ge Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Cholecystokinin Receptor Antagonist Halts Progression of Pancreatic Cancer Precursor Lesions and Fibrosis in Mice
- (2014) Jill P. Smith et al. PANCREAS
- Cholecystokinin and pancreatic cancer: the chicken or the egg?
- (2013) Jill P. Smith et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Inflammatory networks and immune surveillance of pancreatic carcinoma
- (2013) Robert H Vonderheide et al. CURRENT OPINION IN IMMUNOLOGY
- The Gastrointestinal Tumor Microenvironment
- (2013) Michael Quante et al. GASTROENTEROLOGY
- Role of Immune Cells and Immune-Based Therapies in Pancreatitis and Pancreatic Ductal Adenocarcinoma
- (2013) Lei Zheng et al. GASTROENTEROLOGY
- Screening and Surgical Outcomes of Familial Pancreatic Cancer
- (2013) Adam W. Templeton et al. SURGICAL CLINICS OF NORTH AMERICA
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- An International Multicenter Randomized Controlled Trial of G17DT in Patients With Pancreatic Cancer
- (2012) Andrew D. Gilliam et al. PANCREAS
- Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms
- (2011) Mikayel Mkrtichyan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- CCK1 and CCK2 Receptors Are Expressed on Pancreatic Stellate Cells and Induce Collagen Production
- (2010) Marc J. Berna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Growth of Human Pancreatic Cancer Is Inhibited by Down-Regulation of Gastrin Gene Expression
- (2009) Gail L. Matters et al. PANCREAS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started